Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: Results of a multicenter, prospective survey

Critical Care Medicine

Volumn 36, Issue 1, 2008, Pages 145-150

  Gando, Satoshi ^a   Saitoh, Daizoh ^b   Ogura, Hiroshi ^c   Mayumi, Toshihiko ^d   Koseki, Kazuhide ^e   Ikeda, Toshiaki ^f   Ishikura, Hiroyasu ^g   Iba, Toshiaki ^h   Ueyama, Masashi ⁱ   Eguchi, Yutaka ^j   Ohtomo, Yasuhiro ^k   Okamoto, Kohji ^l   Kushimoto, Shigeki ^m   Endo, Shigeatsu ⁿ   Shimazaki, Shuji ^o  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b National Defense Medical College Research Institute

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Kawaguchi Municipal Medical Center   (Japan)

^f TOKYO MEDICAL UNIVERSITY HACHIOJI MEDICAL CENTER   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^h JUNTENDO UNIVERSITY   (Japan)

ⁱ CHUKYO HOSPITAL   (Japan)

^j SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^k TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^l UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^m NIPPON MEDICAL SCHOOL   (Japan)

ⁿ IWATE MEDICAL UNIVERSITY   (Japan)

^o KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Critical illness; Diagnosis; Disseminated intravascular coagulation; International Society on Thrombosis and Haemostasis; Natural history; Systemic inflammatory response syndrome

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING INHIBITOR; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; PLASMA SUBSTITUTE; PROTHROMBIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRINOGEN BLOOD LEVEL; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTENSIVE CARE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TERTIARY HEALTH CARE; THROMBOCYTE; THROMBOCYTE COUNT;

EID: 37548998584     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000295317.97245.2D     Document Type: Article

References (19)

1. Levi M, ten Cate H: Disseminated intravascular coagulation. N Engl J Med 1999; 341:586-592
2. Kobayashi N, Maekawa T, Takeda M, et al: Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol 1987; 49:848-852
3. Taylor FB Jr, Toh CH, Hoots WK, et al: Toward definition, clinical and laboratory criteria, and scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86:1327-1330
4. Bakhtiari K, Meijers JCM, de Jonge E, et al: Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004; 32:2416-2421
5. Toh CH, Downey C: Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagl Fibrinolysis 2005; 16:69-74
6. Gando S, Iba T, Eguchi Y, et al: A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria. Crit Care Med 2006; 34:625-631
7. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference committee. Definition for sepsis and organ failure and guidelines for the use innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
8. Knaus WA, Draper EA, Wanger DP, et al: APACHE II: A severity classification system. Crit Care Med 1985; 13:818-829
9. Vincent JL, de Mendonça A, Cantraine F, et al: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Crit Care Med 1998; 26:1793-1800
10. Ferreira FL, Bota DP, Bross A, et al: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286:1754-1758
11. Drews RE, Weinberger SE: Thrombocytopenic disorders in critically ill patients. Am J Respir Crit Care Med 2000; 162:347-351
12. Angstwurm MW, Dempfle CE, Spannagl M: New disseminated intravascular coagulation score: A useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit Care Med 2006; 34:314-320
13. Sivula M, Tallgren M, Pettilä V: Modified scores for disseminated intravascular coagulation in the critically ill. Intensive Care Med 2005; 31:1209-1214
14. Gando S, Kameue T, Nanzaki S, et al: Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 1996; 75:224-228
15. Dhainaut JF, Shorr AF, Macias WL, et al: Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure. Crit Care Med 2005; 33:341-348
16. Kinasewitz GT, Zein JG, Lee GL, et al: Prognostic value of a simple evolving disseminated intravascular score in patients with severe sepsis. Crit Care Med 2005; 33:2214-2221
17. Levi M: Settling the score for disseminated intravascular coagulation. Crit Care Med 2005; 33:2417-2418
18. Wada H, Wakita Y, Nakase T, et al: Outcome of disseminated intravascular coagulation in relation to the score when the treatment was begun. Thromb Haemost 1995; 74:848-852
19. Hoots WK: Non-overt disseminated intravascular coagulation: Definition and pathophysiological implication. Blood Rev 2002; 16(Suppl I):S3-S9